drugset / Trial / NCT01677923

Obesity in Children and Adolescents: Associated Risks and Early Intervention

NCT01677923 ↗

Phase 3 Completed 182 enrolled Lithuanian University of Health Sciences
RandomizedParallel-groupOpen-labelTreatment

Summary

The investigators hypothesize that Metformin decreases weight, normalizes lipid profile and increases insulin sensitivity; the study team hope to get better effect of weight decrease and metabolic processes repair in the intensive treatment group with intervention of physical activity, diet correction and Metformin use.

Timeline

Start
2013-05
Primary completion
2014-04
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 500 mg —

Indications